Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$79.74
-2.73-3.31%
At close: -
$79.74
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Vaxcyte (NASDAQ:PCVX) Stock, Analyst Ratings, Price Targets, Forecasts
Vaxcyte Inc has a consensus price target of $119.4 based on the ratings of 12 analysts. The high is $175 issued by B of A Securities on February 9, 2024. The low is $14 issued by Needham on February 11, 2025. The 3 most-recent analyst ratings were released by Needham, Goldman Sachs, and Needham on February 11, 2025, December 20, 2024, and November 6, 2024, respectively. With an average price target of $96.33 between Needham, Goldman Sachs, and Needham, there's an implied 20.81% upside for Vaxcyte Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Needham
Goldman Sachs
Mizuho
B of A Securities
Leerink Partners
1calculated from analyst ratings
Analyst Ratings for Vaxcyte
Data brought to you by Benzinga APIs
FAQ
What is the target price for Vaxcyte (PCVX) stock?
The latest price target for Vaxcyte (NASDAQ:PCVX) was reported by Needham on February 11, 2025. The analyst firm set a price target for $14.00 expecting PCVX to fall to within 12 months (a possible -82.44% downside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vaxcyte (PCVX)?
The latest analyst rating for Vaxcyte (NASDAQ:PCVX) was provided by Needham, and Vaxcyte reiterated their buy rating.
When was the last upgrade for Vaxcyte (PCVX)?
There is no last upgrade for Vaxcyte
When was the last downgrade for Vaxcyte (PCVX)?
There is no last downgrade for Vaxcyte.
When is the next analyst rating going to be posted or updated for Vaxcyte (PCVX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaxcyte, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaxcyte was filed on February 11, 2025 so you should expect the next rating to be made available sometime around February 11, 2026.
Is the Analyst Rating Vaxcyte (PCVX) correct?
While ratings are subjective and will change, the latest Vaxcyte (PCVX) rating was a reiterated with a price target of $14.00 to $14.00. The current price Vaxcyte (PCVX) is trading at is $79.74, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.